Rats received intraperitoneal injection of thiamine (125 mg'/kg body wt) for 4 consecutive days. There was less inhibition by ATP (9% ± 2%) of the pyruvate dehydrogenase complex of isolated liver mitochondria from treated rats than in liver mitochondria from control rats (30% ± 8%). The liver mitochondria of the treated animals contained about 25% more thiamine pyrophosphate than the mitochondria of the controls (0.48 ± 0.03 and 0.36 ± 0.01 nmoles/mg mitochondrial protein, respectively) .
Introduction
Subacute necrotizing encephalomyelopathy or Leigh's disease [10] is an inborn error of metabolism [9] characterized by symmetrical lesions of the brainstem. Two theories on the cause of the disease have been proposed: the first based on the demonstration of a deficiency of pyruvate carboxylase [9] subsequently confirmed by Yoshida et al. [18] , Delvin et al. [6] , and Tang et al. [17] and the second based on a deficiency of thiamine triphosphate, caused by inhibition of thiamine diphosphate: ATP-phosphotransferase by specific inhibitors circulating in the body fluids of affected patients [3] .
Thiamine given in high doses to a patient suffering from Leigh's disease does, at least temporarily, improve the clinical condition, while the high blood lactic acid and pyruvic acid concentrations decrease after administration of thiamine [5] . Concomitantly, the blood 617 /3-hydroxybutyrate and acetoacetate concentrations increased. These data have been interpreted as an activation of the pyruvate dehydrogenase complex by thiamine [5, 8] .
Roche and Reed [14] have demonstrated recently that thiamine pyrophosphate inhibits the phosphorylation of the pyruvate dehydrogenase, thereby maintaining the pyruvate dehydrogenase complex in its active form. The question arises, therefore, as to whether administration of high doses of thiamine can maintain the pyruvate dehydrogenase complex in the nonphosphorylated active form. Rats received intraperitoneal injections of high doses of thiamine. The activity of pyruvate dehydrogenase of liver mitochondria was then determined under phosphorylating and nonphosphorylating conditions. It was found that thiamine treatment of the rats resulted in less inhibition by ATP of liver pyruvate dehydrogenase as compared with controls.
Materials and Methods
Young adult, female rats of the Wistar strain of about 200 g, body wt, received daily intrapei'itoneal injections of 1 ml solution containing 25 mg thiamine dichloride in 0.9% NaCl for 4 consecutive days. The animals were killed on the 5th day. Liver mitochondria were prepared in 0.25 M sucrose as described by Schneider [15] . The rate of oxygen uptake was measured polarographically [2] in a medium which had the following composition: KoHPO 4 , 10 mM; KC1, 15 ITIM; MgCl 2 , 5 mM; EDTA, 2 mM; trishydroxymethylaminomethane hydrochloride, 50 mM; fiuorocitrate to inhibit further oxidation of citrate, 0.1 mM; carboxyl cyanide ^-trifluoromethoxyphenyl hydrazone as an uncoupler, 1 fiM; oligomycin to inhibit the mitochondrial ATPase, 6 fig/ml; malate to generate an adequate supply of oxaloacetate, 5 HIM; pyruvate, 0.5 ITIM; ADP or ATP, 5 mM.
Protein was determined by the biuret method, using bovine serum albumin as a standard.
Mitochondrial extracts were prepared with 18% HC1O 4 , followed by neutralization with 30% KHCO 3 . After standing for 1 hr at 0° the mixture was centrifuged and the supernatant analyzed for thiamine phosphates as described by Cooper et al. [3] .
All reagents used were of analytical grade.
Results Table I summarizes the results on the rates of oxygen uptake of rat liver mitochondria with pyruvate and malate as substrate, in the medium described under materials and methods in the presence of ADP or ATP.
In the presence of ADP and an uncoupler, the pyruvate dehydrogenase is maximally activated because the intramitochondrial ATP level is essentially zero [7] . The same experiment repeated in the presence of ATP and oligomycin to prevent the hydrolysis of ATP demonstrates inhibition of the rate of oxygen uptake. That the rate of oxygen uptake is directly related to the activity of pyruvate dehydrogenase in this system has been demonstrated by showing that the ratio of acetylCoA over CoA is decreased in the presence of ATP and that, furthermore, the rate of oxidation of palmitoyl carnithine is higher than that of pyruvate and malate [1, 16] . Citrate synthase is, in this system, not rate limiting. Liver mitochondria prepared from thiaminetreated rats show considerably less inhibition of the pyruvate dehydrogenase by ATP than the nontreated controls (Table I) . Administration of thiamine can apparently maintain the pyruvate dehydrogenase in the active, nonphosphorylated form, which may be expected from the observations of Roche and Reed [14] . Therefore, the mitochondria prepared from thiamine- treated rats have to contain more thiamine diphosphate than those of the controls. Electrophoretic analysis of mitochondrial extracts at pH 5.2 demonstrated that the only fraction which could be made visible with the fluorescing ferricyanide reagent, had the same electrophoretic mobility as thiamine diphosphate. This was observed for control animals as well as for thiamine-treated animals. Subsequent analyses of mitochondrial extracts for thiamine derivatives were therefore carried out on whole extracts, without electrophoretic separation. The results are given in Table II . Liver mitochondria prepared from thiamine-treated rats contain significantly more thiamine diphosphate than do liver mitochondria prepared from control animals.
Discussion
Pincus and associates [12, 13] have advocated the use of thiamine in cases of Leigh's disease as suggested by Lonsdale [11] . That administration of thiamine has a beneficial effect for those patients seems to be well documented [5, 8, [11] [12] [13] . The rationale for this treatment seems to be the role of thiamine triphosphate in neurophysiologic processes [12] . However, the effect of thiamine treatment on the blood lactate and pyruvate level in cases of Leigh's disease suggested in addition a different mode of action of this vitamin. The decrease in blood lactate and pyruvate and the concomitant increase in /3-hydroxybutyrate and acetoacetate observed after institution of the thiamine therapy could be explained by postulating an activation of the pyruvate dehydrogenase complex [5, 8] . Thiamine pyrophosphate was found by Roche and Reed [14] to inhibit the phosphorylation of pyruvate dehydrogenase. A high intramitochondrial concentration of thiamine pyrophosphate will therefore maintain the pyruvate dehydrogenase in its active form.
Phenomenologically, this could amount to the same as postulating an activation of the enzyme complex. If this mechanism is also operative for the effect of thiamine in cases of Leigh's disease it is necessary to demonstrate that thiamine treatment results in a lower sensitivity to ATP inhibition of the pyruvate dehydrogenase complex. The data presented in Table I demonstrate that this is indeed the case. Table II demonstrates, furthermore, that treatment of the rats with high doses of thiamine results in an increased content of thiamine pyrophosphate in the mitochondria. It is therefore highly likely that the mechanism suggested by Reed and Roche [14] is also operative in the case of the thiamine-treated rats and consequently also in cases of Leigh's disease treated with high doses of thiamine.
The present findings do not exclude a role of thiamine triphosphate in the ethiology of the neuropathologic findings as observed in Leigh's disease [3, 4] . The maintainance of the pyruvate dehydrogenase complex in its active form, as demonstrated here, is, however, an effect of the thiamine administration. How far interference by the thiamine therapy with a physiologic control mechanism has any adverse effects remains to be established in future investigations.
Summary
Intraperitoneal injection in rats of high doses of thiamine resulted in an increased content of thiamine pyrophosphate of the liver mitochondria. Concomitantly a decreased sensitivity to inhibition by ATP of liver pyruvate dehydrogenase was found. This result has been related to the earlier observed decrease in blood lactate and pyruvate after institution of thiamine therapy in patients suffering from Leigh's disease.
